Julie Tibbets|Sarah Wicks
Leveraging Investigator-Initiated Trials in Rare Disease Drug Development
Life Sciences Perspectives ·
Understanding Data Monitoring Committee Conflict of Interest Limitations
Life Sciences Perspectives ·